Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

501. Incidence of dementia in long-term hormone users Full Text available with Trip Pro

Incidence of dementia in long-term hormone users Results from epidemiologic studies of postmenopausal hormone use and dementia have been conflicting. Investigators from the Women's Health Initiative Memory Study reported that the incidence of dementia in women aged >/=65 years assigned to hormone use was increased. Here the authors report results from a prospective cohort study of 2,906 dementia-free women (1,519 hormone users and 1,387 hormone nonusers) aged > or =75 years who were recruited (...) from a Southern California health plan in 1999 and followed through 2003. Cognitive status was assessed annually using the Telephone Interview of Cognitive Status-modified, supplemented by the Telephone Dementia Questionnaire and medical record review. The mean self-reported age at initiation of hormone use was 48.3 years for users of estrogen alone (n = 1,072) and 54.9 years for users of estrogen plus progestin (n = 447); self-reported mean durations of hormone use were 30.5 years and 23.2 years

2008 EvidenceUpdates

502. Community based occupational therapy improved daily functioning in older patients with dementia

Community based occupational therapy improved daily functioning in older patients with dementia Community based occupational therapy improved daily functioning in older patients with dementia | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Community based occupational therapy improved daily functioning in older patients with dementia Article Text Therapuetics Community based occupational therapy improved daily functioning in older

2008 Evidence-Based Medicine

503. Dementia. (Abstract)

Dementia. 18378944 2008 04 21 2008 04 01 1539-3704 148 7 2008 Apr 01 Annals of internal medicine Ann. Intern. Med. In the clinic. Dementia. ITC4-1-ITC4-16 Blass David M DM Rabins Peter V PV eng Journal Article Review United States Ann Intern Med 0372351 0003-4819 AIM IM Dementia diagnosis prevention & control therapy Hospitalization Humans Patient Education as Topic Referral and Consultation 245 2008 4 2 9 0 2008 4 22 9 0 2008 4 2 9 0 ppublish 18378944 148/7/ITC4-1 10.7326/0003-4819-148-7

2008 Annals of Internal Medicine

504. Prevalence of cognitive impairment without dementia in the United States. Full Text available with Trip Pro

Prevalence of cognitive impairment without dementia in the United States. Cognitive impairment without dementia is associated with increased risk for disability, increased health care costs, and progression to dementia. There are no population-based prevalence estimates of this condition in the United States.To estimate the prevalence of cognitive impairment without dementia in the United States and determine longitudinal cognitive and mortality outcomes.Longitudinal study from July 2001 (...) a diagnosis of normal cognition, cognitive impairment without dementia, or dementia. National prevalence rates were estimated by using a population-weighted sample.In 2002, an estimated 5.4 million people (22.2%) in the United States age 71 years or older had cognitive impairment without dementia. Prominent subtypes included prodromal Alzheimer disease (8.2%) and cerebrovascular disease (5.7%). Among participants who completed follow-up assessments, 11.7% with cognitive impairment without dementia

2008 Annals of Internal Medicine

505. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. (Abstract)

Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia.The targeted literature search included evidence related to the effectiveness of 5 U.S. Food and Drug Administration-approved pharmacologic therapies (...) for dementia for outcomes in the domains of cognition, global function, behavior/mood, and quality of life/activities of daily living. RECOMMENDATION 1: Clinicians should base the decision to initiate a trial of therapy with a cholinesterase inhibitor or memantine on individualized assessment. (Grade: weak recommendation, moderate-quality evidence.) RECOMMENDATION 2: Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication

2008 Annals of Internal Medicine

506. Sensitivity and specificity of the clock drawing test, incorporating Rouleau scoring system, as a screening instrument for questionable and mild dementia: Scale development (Abstract)

Sensitivity and specificity of the clock drawing test, incorporating Rouleau scoring system, as a screening instrument for questionable and mild dementia: Scale development The objective of this study was to validate the Rouleau scoring system for the Clock Drawing Test (CDT) in northern Taiwan, a non-English speaking area, to increase its generalization by detecting subjects with questionable dementia (QD) from normal controls (NC) and subjects with mild dementia (AD). The system consists

2008 EvidenceUpdates

507. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. Full Text available with Trip Pro

Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. To provide estimates of survival after onset of dementia by age, sex, self reported health, disability, and severity of cognitive impairment.Analysis of participants from prospective population based cohort study in 1991-2003, with follow-up of dementia status in all individuals after two and six years (in one centre) and 10 years and in subsamples additionally at six and eight years (...) and mortality until 2005.Multicentre population based study in England and Wales: two rural and three urban centres.438 participants who developed dementia from a population based study of 13 004 individuals aged 65 years and over drawn from primary care population registers.Sociodemographic factors, cognitive function, specific health conditions, and self reported health collected at each interview. Cox's proportional hazards regression models were used to identify predictors of mortality from the selected

2008 BMJ

508. Personal Assistance for Older Adults (65+) Without Dementia Full Text available with Trip Pro

Personal Assistance for Older Adults (65+) Without Dementia Personal Assistance for Older Adults (65+) Without Dementia - Montgomery - 2008 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access Personal Assistance for Older Adults (65+) Without Dementia University Lecturer E-mail address: +44 1865 280 325 | Fax: +44 1865 270 324 The Centre (...) their own homes (e.g., in nursing homes) were excluded. Studies in which the majority (51% or more) of participants had been diagnosed as suffering from dementia at baseline were excluded as their reasons for receiving assistance and goals might differ from other older adults. Types of interventions In consultation with experts and the reference group, the reviewers sought to determine what minimal amount of assistance could be offered and still follow the personal assistance model for this population

2008 Campbell Collaboration

509. Befriending carers of people with dementia: randomised controlled trial. Full Text available with Trip Pro

Befriending carers of people with dementia: randomised controlled trial. To evaluate the effectiveness of a voluntary sector based befriending scheme in improving psychological wellbeing and quality of life for family carers of people with dementia.Single blind randomised controlled trial.Community settings in East Anglia and London.236 family carers of people with primary progressive dementia.Contact with a befriender facilitator and offer of match with a trained lay volunteer befriender

2008 BMJ Controlled trial quality: predicted high

510. Carers of people with dementia: no benefit of adding befriending initiative to usual care

Carers of people with dementia: no benefit of adding befriending initiative to usual care Carers of people with dementia: no benefit of adding befriending initiative to usual care | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Carers of people with dementia: no benefit of adding befriending initiative to usual care Article Text Therapeutics Carers of people with dementia: no benefit of adding befriending initiative to usual care Statistics

2008 Evidence-Based Mental Health

511. Review: Cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia Full Text available with Trip Pro

Review: Cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia Review: Cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: Cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia Article Text Therapeutics Review: Cholinesterase inhibitors and memantine

2008 Evidence-Based Mental Health

512. Mortality in people with dementia taking antipsychotics higher than in those taking other psychiatric medications

Mortality in people with dementia taking antipsychotics higher than in those taking other psychiatric medications Mortality in people with dementia taking antipsychotics higher than in those taking other psychiatric medications | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mortality in people with dementia taking antipsychotics higher than in those taking other psychiatric medications Article Text Prognosis Mortality in people

2008 Evidence-Based Mental Health

513. Age, sex, and functional impairment predicted risk of mortality in incident dementia at 14 years

Age, sex, and functional impairment predicted risk of mortality in incident dementia at 14 years Age, sex, and functional impairment predicted risk of mortality in incident dementia at 14 years | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Age, sex, and functional impairment predicted risk of mortality in incident dementia at 14 years Article Text Prognosis Age, sex, and functional impairment predicted risk of mortality in incident

2008 Evidence-Based Medicine

514. Occupational therapy is cost-effective for older people with dementia and their caregivers

Occupational therapy is cost-effective for older people with dementia and their caregivers Occupational therapy is cost-effective for older people with dementia and their caregivers | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Occupational therapy is cost-effective for older people with dementia and their caregivers Article Text Therapeutics Occupational therapy is cost-effective for older people with dementia and their caregivers Statistics

2008 Evidence-Based Mental Health

515. New use of antipsychotic drugs in elderly people with dementia may increase the mortality risk

New use of antipsychotic drugs in elderly people with dementia may increase the mortality risk New use of antipsychotic drugs in elderly people with dementia may increase the mortality risk | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here New use of antipsychotic drugs in elderly people with dementia may increase the mortality risk Article Text Aetiology New use of antipsychotic drugs in elderly people with dementia may increase

2008 Evidence-Based Mental Health

516. Review: Psychological interventions for caregivers of people with dementia

Review: Psychological interventions for caregivers of people with dementia Review: Psychological interventions for caregivers of people with dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: Psychological interventions for caregivers of people with dementia Article Text Therapeutics Review: Psychological interventions for caregivers of people with dementia Statistics from Altmetric.com Request Permissions If you

2008 Evidence-Based Mental Health

517. The dementia screening questionnaire for individuals with intellectual disabilities has high sensitivity and specificity in adults with Down's syndrome Full Text available with Trip Pro

The dementia screening questionnaire for individuals with intellectual disabilities has high sensitivity and specificity in adults with Down's syndrome The dementia screening questionnaire for individuals with intellectual disabilities has high sensitivity and specificity in adults with Down's syndrome | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn (...) more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The dementia screening questionnaire for individuals with intellectual disabilities

2008 Evidence-Based Mental Health

518. Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis

Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

519. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline

Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M CRD summary The review (...) concluded that cholinesterase inhibitors and memantine can result in statistically significant but clinically marginal improvement in measures of cognition and global assessment in patients with dementia. This review was generally well conducted and the authors' conclusions are likely to be reliable. Authors' objectives To determine the effectiveness of cholinesterase inhibitors and the neuropeptide-modifying agent memantine for the treatment of dementia. Searching Cochrane Central Register

2008 DARE.

520. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis

Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.